| Boosting the oral bioavailability of anticancer drugs through intentional drug–drug interactions ED Eisenmann, Z Talebi, A Sparreboom, SD Baker Basic & clinical pharmacology & toxicology 130, 23-35, 2022 | 41 | 2022 |
| Role of OATP1B1 and OATP1B3 in drug-drug interactions mediated by tyrosine kinase inhibitors DA Garrison, Z Talebi, ED Eisenmann, A Sparreboom, SD Baker Pharmaceutics 12 (9), 856, 2020 | 40 | 2020 |
| Gilteritinib Inhibits Glutamine Uptake and Utilization in FLT3-ITD–Positive AML ME Zavorka Thomas, X Lu, Z Talebi, JY Jeon, DR Buelow, AA Gibson, ... Molecular cancer therapeutics 20 (11), 2207-2217, 2021 | 37 | 2021 |
| Applications of bacterial cellulose as a natural polymer in tissue engineering M Bouhlouli, M Pourhadi, F Karami, Z Talebi, J Ranjbari, A Khojasteh ASAIO Journal 67 (7), 709-720, 2021 | 26 | 2021 |
| Endogenous biomarkers for SLC transporter-mediated drug-drug interaction evaluation Y Li, Z Talebi, X Chen, A Sparreboom, S Hu Molecules 26 (18), 5500, 2021 | 24 | 2021 |
| In Vitro and In Vivo Inhibition of MATE1 by Tyrosine Kinase Inhibitors ME Uddin, Z Talebi, S Chen, Y Jin, AA Gibson, AM Noonan, X Cheng, ... Pharmaceutics 13 (12), 2004, 2021 | 16 | 2021 |
| The role of OATP1B1 and OATP1B3 transporter polymorphisms in drug disposition and response to anticancer drugs: a review of the recent literature N Anabtawi, T Drabison, S Hu, A Sparreboom, Z Talebi Expert Opinion on Drug Metabolism & Toxicology 18 (7-8), 459-468, 2022 | 14 | 2022 |
| Interaction of antifungal drugs with CYP3A-and OATP1B-mediated venetoclax elimination ED Eisenmann, DA Garrison, Z Talebi, Y Jin, JA Silvaroli, JG Kim, ... Pharmaceutics 14 (4), 694, 2022 | 13 | 2022 |
| Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial ET Roussos Torres, WJ Ho, L Danilova, JA Tandurella, J Leatherman, ... Nature Cancer, 1-14, 2024 | 11 | 2024 |
| Cellular and molecular mechanisms in perioperative hepatic protection: a review of current interventions Z Talebi, H Peyvandi, A Dabbagh Journal of Cellular & Molecular Anesthesia 2 (2), 2017 | 10 | 2017 |
| Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in acute myeloid leukemia ME Zavorka Thomas, JY Jeon, Z Talebi, DR Buelow, J Silvaroli, ... Blood Advances 5 (23), 5041-5046, 2021 | 9 | 2021 |
| Targeting OCT2 with duloxetine to prevent oxaliplatin-induced peripheral neurotoxicity MR Nepal, H Taheri, Y Li, Z Talebi, ME Uddin, Y Jin, DF DiGiacomo, ... Cancer research communications 2 (11), 1334-1343, 2022 | 6 | 2022 |
| MATE1 deficiency exacerbates dofetilide-induced proarrhythmia ME Uddin, ED Eisenmann, Y Li, KM Huang, DA Garrison, Z Talebi, ... International journal of molecular sciences 23 (15), 8607, 2022 | 6 | 2022 |
| Cardiovascular pharmacology in pediatric patients with congenital heart disease A Dabbagh, Z Talebi, S Rajaei Congenital heart disease in pediatric and adult patients: anesthetic and …, 2023 | 5 | 2023 |
| Itraconazole-induced increases in gilteritinib exposure are mediated by CYP3A and OATP1B DA Garrison, Y Jin, Z Talebi, S Hu, A Sparreboom, SD Baker, ... Molecules 27 (20), 6815, 2022 | 5 | 2022 |
| Perioperative pain: molecular mechanisms and future perspectives Z Talebi, A Dabbagh Journal of Cellular & Molecular Anesthesia 2 (3), 2017 | 4 | 2017 |
| Darolutamide does not interfere with OATP‐mediated uptake of docetaxel SAJ Buck, Z Talebi, T Drabison, Y Jin, AA Gibson, P Hu, P de Bruijn, ... International Journal of Cancer, 2024 | 3 | 2024 |
| Evaluation of medication reconciliation process in internal medicine wards of an academic medical center by a pharmacist: errors and risk factors S Ziaie, G Mehralian, Z Talebi Internal and Emergency Medicine 17 (2), 377-386, 2022 | 3 | 2022 |
| Cardiovascular pharmacology in adult patients undergoing cardiac surgery A Dabbagh, A Tajbakhsh, Z Talebi, S Rajaei Postoperative Critical Care for Adult Cardiac Surgical Patients, 75-142, 2018 | 3 | 2018 |
| Transforming Growth Factor Beta 2 (TGFB2) and Interferon Gamma Receptor 2 (IFNGR2) MRNA Levels in the Brainstem Tumor Microenvironment (TME) Significantly Impact Overall … S Qazi, Z Talebi, V Trieu Biomedicines 12 (1), 191, 2024 | 2 | 2024 |
Alex SparreboomProfessor and Lucius A. Wing Chair, The Ohio State University在 osu.edu 的电子邮件经过验证
